Back to search results

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Johns Hopkins Medicine SKCCC, Baltimore, Maryland, United States

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

  • OU Health, Stephenson Cancer Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Christine Pappaterra) · christine-pappaterra@ou.edu
    Contact: Principal Investigator (Laura Holman, MD)

  • University of Texas MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Kerri Fernandes) · kefernan@mdanderson.org
    Contact: Study coordinator (Mariana Gallardo) · mgallardo2@mdanderson.org
    Contact: Principal Investigator (Amir Jazaeri, MD)
Study leads

  • Amir Jazaeri, MD

    Study Chair

    University of Texas MD Anderson Center

View source on ClinicalTrials.gov(opens in a new tab)